(Q33877651)

29 July 2017

The 5-HT(1A) receptor antagonist robalzotan completely reverses citalopram-induced inhibition of serotonergic cell firing (English)

1 reference

29 July 2017

Arborelius L

1

1 reference

29 July 2017

Wallsten C

series ordinal

2

1 reference

29 July 2017

Ahlenius S

series ordinal

3

1 reference

29 July 2017

Svensson TH

series ordinal

4

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 October 1999

1 reference

European Journal of Pharmacology

29 July 2017

1 reference

29 July 2017

382

1 reference

29 July 2017

2

1 reference

29 July 2017

133-138

1 reference

The 5-HT1A receptor antagonist (S)-UH-301 blocks the qR)-8-OH-DPAT-induced inhibition of serotonergic dorsal raphe cell firing in the rat

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900592-0

5-HT1A receptor antagonists increase the activity of serotonergic cells in the dorsal raphe nucleus in rats treated acutely or chronically with citalopram

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900592-0

The 5-HT1A receptor antagonist (S)-UH-301 augments the increase in extracellular concentrations of 5-HT in the frontal cortex produced by both acute and chronic treatment with citalopram

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900592-0

Pindolol Induces a Rapid Improvement of Depressed Patients Treated With Serotonin Reuptake Inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900592-0

Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT1A antagonists.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900592-0

Electrophysiological and neurochemical evidence that pindolol has agonist properties at the 5-HT1A autoreceptor in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900592-0

Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT1A receptor antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900592-0

Interaction between a selective 5-HT1A receptor antagonist and an SSRI in vivo: effects on 5-HT cell firing and extracellular 5-HT

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900592-0

Inhibition of median and dorsal raphe neurones following administration of the selective serotonin reuptake inhibitor paroxetine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900592-0

Randomised, double-blind, placebo-controlled trial of pindolol in combination with fluoxetine antidepressant treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900592-0

How long should pindolol be associated with paroxetine to improve the antidepressant response?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900592-0

10.1016/S0014-2999(99)00592-0

7 January 2021

Identifiers

DOI

1 reference

29 July 2017

1 reference